Retracted: Study of ivermectin and mebendazole for cancer removed by publisher
A study claiming real-world outcomes for ivermectin and mebendazole in cancer patients has been retracted and removed by its publisher. What happened between publication and retraction—and why did this paper’s run come to such an abrupt end? The article traces the story of the study and its removal, offering a closer look at a case where publication was not the end of the process. Read the full account to see what’s known about the retraction and why it matters.